ES2988850T3 - Composiciones para su uso en el tratamiento del trastorno de diarrea congénita - Google Patents

Composiciones para su uso en el tratamiento del trastorno de diarrea congénita Download PDF

Info

Publication number
ES2988850T3
ES2988850T3 ES18810153T ES18810153T ES2988850T3 ES 2988850 T3 ES2988850 T3 ES 2988850T3 ES 18810153 T ES18810153 T ES 18810153T ES 18810153 T ES18810153 T ES 18810153T ES 2988850 T3 ES2988850 T3 ES 2988850T3
Authority
ES
Spain
Prior art keywords
composition
crofelemer
subject
per day
cdd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES18810153T
Other languages
English (en)
Spanish (es)
Inventor
Lisa Conte
Pravin Chaturvedi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Napo Pharmaceuticals Inc
Original Assignee
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Napo Pharmaceuticals Inc filed Critical Napo Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2988850T3 publication Critical patent/ES2988850T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
ES18810153T 2017-05-31 2018-05-31 Composiciones para su uso en el tratamiento del trastorno de diarrea congénita Active ES2988850T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762513251P 2017-05-31 2017-05-31
PCT/US2018/035468 WO2018222919A1 (en) 2017-05-31 2018-05-31 Methods and compositions for treating congenital diarrhea disorder

Publications (1)

Publication Number Publication Date
ES2988850T3 true ES2988850T3 (es) 2024-11-21

Family

ID=64455032

Family Applications (1)

Application Number Title Priority Date Filing Date
ES18810153T Active ES2988850T3 (es) 2017-05-31 2018-05-31 Composiciones para su uso en el tratamiento del trastorno de diarrea congénita

Country Status (12)

Country Link
US (2) US11857510B2 (enExample)
EP (1) EP3634581B8 (enExample)
JP (1) JP2020525407A (enExample)
CN (1) CN110831667A (enExample)
AU (1) AU2018278312B2 (enExample)
CA (1) CA3065797A1 (enExample)
DK (1) DK3634581T3 (enExample)
ES (1) ES2988850T3 (enExample)
FI (1) FI3634581T3 (enExample)
IL (1) IL270984B1 (enExample)
JO (1) JOP20190275A1 (enExample)
WO (1) WO2018222919A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
WO2021257089A1 (en) * 2020-06-19 2021-12-23 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0214317B1 (fr) 1985-08-30 1988-08-17 Societe Des Produits Nestle S.A. Produit diététique à activité dépurative et anti-diarrhéique et son procédé de préparation
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
SI9011933A (sl) 1990-10-15 1998-06-30 TANIN SEVNICA Kemična industrija p.o. Kostanjev taninski ekstrakt, postopek za njegovo pridobivanje in njegova uporaba
PT935417E (pt) 1996-10-16 2009-07-17 Napo Pharmaceuticals Inc Formulações entéricas de composições poliméricas antidiarreicas de proantocianidina
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
WO2000047062A2 (en) 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US7235573B2 (en) 2002-09-30 2007-06-26 The Regents Of The University Of California Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
SG195538A1 (en) 2006-05-01 2013-12-30 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
EP2529626B1 (en) 2006-05-01 2017-11-22 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing colon cancer
US20120202876A1 (en) 2009-10-06 2012-08-09 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
CN103370101A (zh) 2010-10-31 2013-10-23 萨利克斯药品有限公司 用于治疗hiv相关性腹泻的方法和组合物
WO2017112953A1 (en) 2015-12-23 2017-06-29 Vanessa Research, Inc. Compositions and methods of treatment for mvid and related diseases
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي

Also Published As

Publication number Publication date
CN110831667A (zh) 2020-02-21
CA3065797A1 (en) 2018-12-06
AU2018278312A1 (en) 2020-01-02
IL270984B1 (en) 2026-01-01
FI3634581T3 (fi) 2024-08-16
IL270984A (en) 2020-01-30
AU2018278312B2 (en) 2024-07-04
DK3634581T3 (da) 2024-08-26
US20240325346A1 (en) 2024-10-03
JP2020525407A (ja) 2020-08-27
US11857510B2 (en) 2024-01-02
WO2018222919A1 (en) 2018-12-06
EP3634581B8 (en) 2024-09-11
US20200108047A1 (en) 2020-04-09
JOP20190275A1 (ar) 2019-11-27
EP3634581B1 (en) 2024-07-31
EP3634581A1 (en) 2020-04-15
EP3634581A4 (en) 2021-02-24

Similar Documents

Publication Publication Date Title
US20240325346A1 (en) Methods and compositions for treating congenital diarrhea disorder
ES2980381T3 (es) Composiciones para usos en el tratamiento de síntomas del tracto urinario inferior, hiperplasia prostática benigna, disfunción eréctil y otras enfermedades o síntomas
JP6063385B2 (ja) Ｈｉｖ関連の下痢を治療するための方法および組成物
ES2985972T3 (es) Composiciones para el tratamiento de la diarrea de ácidos biliares y el síndrome del intestino corto
US20220362209A1 (en) Methods and compositions for treating chemotherapy-induced diarrhea
HK40016516A (en) Compositions for use in treating congenital diarrhea disorder
KR100208969B1 (ko) 찹쌀추출물을 함유하는 항궤양제
HK40016517A (en) Compositions for treating bile acid diarrhea and short bowel syndrome
HK40016517B (en) Compositions for treating bile acid diarrhea and short bowel syndrome
HK40015132A (en) Methods and compositions for treating bile acid diarrhea, diarrhea associated with small intestine resection or gallbladder removal, and short bowel syndrome
WO2021214364A1 (es) Uso terapéutico de un extracto de maqui en la enfermedad de crohn
Cupp Chamomile
KR20090048063A (ko) 나노에멀젼을 유효성분으로 포함하는 치주질환의 치료용조성물